These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 27882657)

  • 1. Using a semi-conductor sequencing-based panel for genotyping of HPV-positive and HPV-negative oropharyngeal cancer: a retrospective pilot study.
    Ham JC; Tops BBJ; Driessen CML; van Raaij AWM; Slootweg PJ; Melchers WJG; Ligtenberg MJL; van Herpen CML
    Clin Otolaryngol; 2017 Jun; 42(3):681-686. PubMed ID: 27882657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frequency of activating PIK3CA mutations in human papillomavirus-positive oropharyngeal cancer.
    Nichols AC; Palma DA; Chow W; Tan S; Rajakumar C; Rizzo G; Fung K; Kwan K; Wehrli B; Winquist E; Koropatnick J; Mymryk JS; Yoo J; Barrett JW
    JAMA Otolaryngol Head Neck Surg; 2013 Jun; 139(6):617-22. PubMed ID: 23787421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor tyrosine kinase profiles and human papillomavirus status in oropharyngeal squamous cell carcinoma.
    Cortelazzi B; Verderio P; Ciniselli CM; Pizzamiglio S; Bossi P; Gloghini A; Gualeni AV; Volpi CC; Locati L; Pierotti MA; Licitra L; Pilotti S; Perrone F
    J Oral Pathol Med; 2015 Oct; 44(9):734-45. PubMed ID: 25495427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
    Rietbergen MM; Snijders PJ; Beekzada D; Braakhuis BJ; Brink A; Heideman DA; Hesselink AT; Witte BI; Bloemena E; Baatenburg-De Jong RJ; Leemans CR; Brakenhoff RH
    Int J Cancer; 2014 May; 134(10):2366-72. PubMed ID: 24249631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based p16 and HPV positivity rates in oropharyngeal cancer in Southeast Scotland.
    Wells LA; Junor EJ; Conn B; Pattle S; Cuschieri K
    J Clin Pathol; 2015 Oct; 68(10):849-52. PubMed ID: 26152733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer.
    Reimers N; Kasper HU; Weissenborn SJ; Stützer H; Preuss SF; Hoffmann TK; Speel EJ; Dienes HP; Pfister HJ; Guntinas-Lichius O; Klussmann JP
    Int J Cancer; 2007 Apr; 120(8):1731-8. PubMed ID: 17236202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of EZH2 pathways for novel epigenetic treatment strategies in oropharyngeal cancer.
    Idris S; Lindsay C; Kostiuk M; Andrews C; Côté DW; O'Connell DA; Harris J; Seikaly H; Biron VL
    J Otolaryngol Head Neck Surg; 2016 Oct; 45(1):54. PubMed ID: 27793210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining molecular phenotypes of human papillomavirus-associated oropharyngeal squamous cell carcinoma: validation of three-class hypothesis.
    Weinberger PM; Yu Z; Kountourakis P; Sasaki C; Haffty BG; Kowalski D; Merkley MA; Rimm DL; Camp RL; Psyrri A
    Otolaryngol Head Neck Surg; 2009 Sep; 141(3):382-9. PubMed ID: 19716018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus and oropharynx cancer: biology, detection and clinical implications.
    Allen CT; Lewis JS; El-Mofty SK; Haughey BH; Nussenbaum B
    Laryngoscope; 2010 Sep; 120(9):1756-72. PubMed ID: 20669304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between HPV-DNA status and p16 protein expression in oropharyngeal squamous cell carcinoma and their clinical significance].
    Huang H; Zhang B; Chen W; Zou SM; Xu ZG
    Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):684-8. PubMed ID: 24332056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomewide gene expression profiles of HPV-positive and HPV-negative oropharyngeal cancer: potential implications for treatment choices.
    Lohavanichbutr P; Houck J; Fan W; Yueh B; Mendez E; Futran N; Doody DR; Upton MP; Farwell DG; Schwartz SM; Zhao LP; Chen C
    Arch Otolaryngol Head Neck Surg; 2009 Feb; 135(2):180-8. PubMed ID: 19221247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of human papillomavirus in anal squamous cell carcinoma.
    Ravenda PS; Magni E; Botteri E; Manzotti M; Barberis M; Vacirca D; Trovato CM; Dell'Acqua V; Leonardi MC; Sideri M; Fazio N; Zampino MG
    Cancer Chemother Pharmacol; 2014 Nov; 74(5):1033-8. PubMed ID: 25209946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proximity ligation-based sequencing for the identification of human papillomavirus genomic integration sites in formalin-fixed paraffin embedded oropharyngeal squamous cell carcinomas.
    Demers I; Balaji H; Feitsma H; Stelloo E; Swennenhuis J; Sergeeva I; Wuerdemann N; van den Hout MFCM; Wagner S; Kremer B; Klussmann JP; Huebbers CU; Speel EM
    J Med Virol; 2024 Aug; 96(8):e29837. PubMed ID: 39105417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ki67 Expression has Prognostic Significance in Relation to Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma.
    Liu J; Zhang M; Rose B; Veillard AS; Jones D; Zhang X; Soon Lee C; Milross C; Hong A
    Ann Surg Oncol; 2015; 22(6):1893-900. PubMed ID: 25404475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
    Trosman SJ; Koyfman SA; Ward MC; Al-Khudari S; Nwizu T; Greskovich JF; Lamarre ED; Scharpf J; Khan MJ; Lorenz RR; Adelstein DJ; Burkey BB
    JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):457-62. PubMed ID: 25742025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIK3CA, HRAS and PTEN in human papillomavirus positive oropharyngeal squamous cell carcinoma.
    Chiosea SI; Grandis JR; Lui VW; Diergaarde B; Maxwell JH; Ferris RL; Kim SW; Luvison A; Miller M; Nikiforova MN
    BMC Cancer; 2013 Dec; 13():602. PubMed ID: 24341335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of transcriptionally active HPV infection in formalin-fixed, paraffin-embedded biopsies of oropharyngeal carcinoma.
    Morbini P; Alberizzi P; Tinelli C; Paglino C; Bertino G; Comoli P; Pedrazzoli P; Benazzo M
    Hum Pathol; 2015 May; 46(5):681-9. PubMed ID: 25708613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic differences between human papillomavirus-positive and -negative oropharyngeal squamous cell carcinomas.
    Biron VL; Mohamed A; Hendzel MJ; Alan Underhill D; Seikaly H
    J Otolaryngol Head Neck Surg; 2012 Apr; 41 Suppl 1():S65-70. PubMed ID: 22569052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 codon 72 polymorphisms in human papillomavirus-negative and human papillomavirus-positive squamous cell carcinomas of the oropharynx.
    Perrone F; Mariani L; Pastore E; Orsenigo M; Suardi S; Marcomini B; DaRiva L; Licitra L; Carbone A; Pierotti MA; Pilotti S
    Cancer; 2007 Jun; 109(12):2461-5. PubMed ID: 17492690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From HPV-positive towards HPV-driven oropharyngeal squamous cell carcinomas.
    Boscolo-Rizzo P; Pawlita M; Holzinger D
    Cancer Treat Rev; 2016 Jan; 42():24-9. PubMed ID: 26547133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.